Sepoy-logo
No Result
View All Result
Monday, May 29, 2023
  • Home
  • News
  • Business
  • Health
  • Tech
  • Lifestyle
  • Economy
  • Crypto
  • Travel
  • Home
  • News
  • Business
  • Health
  • Tech
  • Lifestyle
  • Economy
  • Crypto
  • Travel
No Result
View All Result
SEPOY.NET
No Result
View All Result
Home Health

NRG Oncology study of atezolizumab and chemoradiation for patients with limited-stage small cell lung cancer completes accrual

Nicholas by Nicholas
July 8, 2022
in Health
0

The NRG Oncology/Alliance clinical trial NRG-LU005, examining the addition of the immunotherapy drug atezolizumab combined with chemoradiation for patients with limited-stage small cell lung cancer (SCLC) recently reached the trial’s accrual goal of 506 patients. Despite this trial closing to patient enrollment in the United States, NRG-LU005 will remain open for accrual to sites based in Japan.

At this time, the United States Food and Drug Administration (FDA) has approved the use of atezolizumab in the treatment of metastatic, extensive stage SCLC, however, NRG-LU005 is the first phase III clinical trial to test atezolizumab in the adjuvant curable stage of SCLC.

“There has been an unmet need for new therapies in curable stages of small cell lung cancer for some time. We have conducted NRG-LU005 at a rapid pace, which really reflects the urgency for which new treatments are needed for our patients, and the commitment of our investigators, patients, and their families to be part of potentially practice changing research,” stated Kristin Higgins, MD, of Winship Cancer Institute at Emory University and the Principal Investigator of the NRG-LU005 trial. “We are hopeful that this trial will ultimately lead to more patients being cured of small cell lung cancer.”

Chemotherapy with radiation therapy is the current standard of care for patients with curable limited-stage SCLC which has proven results in decreasing tumor burden, yet patients tend to relapse early and often from this treatment. Adding immunotherapy to the usual treatment could enhance and increase the efficacy of the chemoradiotherapy as well as improve the duration of response and overall survival for patients.

NRG-LU005 randomly assigned patients with limited-stage SCLC to receive chemotherapy (etoposide with cisplatin or carboplatin) and radiation for up to 7 weeks with or without atezolizumab for up to one year. The primary objective of the trial is to compare overall survival between the two treatment regiments. Additionally, secondary objectives include: comparing progression-free survival, overall response rate, rates of local control, distant metastases-free survival, and quality of life between treatments; to characterize immune-mediated and non-immune mediated toxicity and fatigue; and, to evaluate the quality-adjusted survival and the association of blood-based and tissue-based tumor mutation burden. Researchers will also collect biospecimens at varying points before, during, and after treatment for future analysis and will characterize patient-reported symptomatic toxicities. NRG Oncology is grateful to the patients and researchers who are participating in this critical study.

Results from the trial data will be reported as they become available.

“NRG Oncology would like to thank the National Clinical Trials Network sites, research staff, and patients who helped this trial accrue so quickly. The results of this trial could greatly impact and improve outcomes for a larger group of lung cancer patients, and we look forward to the eventual reported data that stems from NRG-LU005,” added Quynh-Thu Le, MD, an NRG Oncology Group Chair, the Co-Director of the Radiation Biology Program at the Stanford Cancer Institute, and the Chair of the Department of Radiation Oncology at Stanford University.

NRG-LU005 is sponsored by the National Cancer Institute and led by NRG Oncology with participation of the National Clinical Trials Network. Genentech Inc., a member of the Roche Group, provided atezolizumab through a Cooperative Research and Development Agreement with NCI and supplemental financial support through NRG .

READ ALSO

Speech therapy can help kids who stutter to communicate more confidently

Valuable tips to help alleviate sleeping discomfort in hot weather

Tags: CancerCellChemotherapyClinical TrialFoodImmunotherapyLung CancerOncologyradiation therapyResearchSmall Cell Lung CancerTumor

Related Posts

Speech therapy can help kids who stutter to communicate more confidently
Health

Speech therapy can help kids who stutter to communicate more confidently

May 29, 2023
Valuable tips to help alleviate sleeping discomfort in hot weather
Health

Valuable tips to help alleviate sleeping discomfort in hot weather

May 27, 2023
Restoring thought-controlled movement after spinal cord injury using a brain-computer interface
Health

Restoring thought-controlled movement after spinal cord injury using a brain-computer interface

May 27, 2023
Look AHEAD study: Type 2 diabetes patients who were physically active in the afternoon have greater reductions in blood sugar
Health

Look AHEAD study: Type 2 diabetes patients who were physically active in the afternoon have greater reductions in blood sugar

May 27, 2023
Health experts and multinationals join together to announce the formation of Movement Health Foundation
Health

Health experts and multinationals join together to announce the formation of Movement Health Foundation

May 27, 2023
Modest reduction in beta-amyloidogenic processing of APP may be a viable strategy to prevent Alzheimer's disease
Health

Modest reduction in beta-amyloidogenic processing of APP may be a viable strategy to prevent Alzheimer's disease

May 27, 2023
Next Post

Researchers develop a modular software system for optimizing biological systems

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

POPULAR NEWS

Roblox Is Unbreakable Trello Is this safe?

Roblox Is Unbreakable Trello Is this safe?

November 4, 2022
Discord Registered Games  Discord Registered Gaming You need to join the Club

Discord Registered Games Discord Registered Gaming You need to join the Club

November 4, 2022
How To Chose the Right Data Analytics Program

How To Chose the Right Data Analytics Program

November 4, 2022
Chandrashekhar Guruji Wiki, Age, Girlfriend, Wife, Family, Biography & More

Chandrashekhar Guruji Wiki, Age, Girlfriend, Wife, Family, Biography & More

November 4, 2022
Heavy explosion on market square in Halle – three injured

Heavy explosion on market square in Halle – three injured

November 4, 2022

EDITOR'S PICK

Your Guide to Mobile Plans

Your Guide to Mobile Plans

December 22, 2022

Robo-Advisor Quirion: Erfahrungen und Kosten

April 28, 2022

Father with four children in need: Dramatic rescue operation in the Rhine

August 24, 2022
DFYAppBiz Review – 33VIP 3,000 Bonuses ,732,034 + OTO 1,2,3,4,5,6,7,8,9 Link Here

DFYAppBiz Review – 33VIP 3,000 Bonuses $1,732,034 + OTO 1,2,3,4,5,6,7,8,9 Link Here

January 31, 2023

About

Sepoy.net is a perfect place for people who want daily updates on news related to business, technology, entertainment, health, cryptocurrency etc.

Contact: [email protected]

Major Categories

News

Business

Tech

Economy

 

Recent Posts

  • Targeted Advertising on Connected TV: Reaching the Right Viewers at the Right Time
  • Anti-Semitic relief: Brandenburger “Judensau” is covered
  • Speech therapy can help kids who stutter to communicate more confidently

Pages

  • About Us
  • Contact Us
  • Disclaimer
  • DMCA
  • Home
  • Privacy Policy

© 2023 Sepoy.net

No Result
View All Result
  • Home
  • Business
  • News
  • Health
  • Tech
  • Science
  • Lifestyle
  • Travel

© 2023 Sepoy.net